Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2010
06/08/2010CA2283684C Down-regulation of gene expression by colorectal administration of synthetic oligonucleotides
06/08/2010CA2266342C Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
06/03/2010WO2010063011A2 Methods for the treatment of infections and tumors
06/03/2010WO2010062955A1 Treating neoplasms with neurotoxin
06/03/2010WO2010062854A2 Methods and compositions for using bleomycin-derivatized microbubbles
06/03/2010WO2010062742A2 Methods for freparation and use of marrow infiltrating lymphocytes (mils)
06/03/2010WO2010062686A2 Imidazol-4-one and imidazole-4-thione compounds
06/03/2010WO2010062571A1 Mtor kinase inhibitors for oncology indications and diseases associated with the mtor/p13k/akt pathway
06/03/2010WO2010062507A1 Disubstituted phthalazine hedgehog pathway antagonists
06/03/2010WO2010062506A2 Decahydro-1h-indenoquinolinone and decahydro-3h-cyclopentaphenanthridinone cyp17 inhibitors
06/03/2010WO2010062401A2 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010WO2010062265A1 Therapeutic macrolide compounds and their use
06/03/2010WO2010062159A1 Bioactive compounds
06/03/2010WO2010062144A2 Ethacrynic acid-containing composition and method for prevention and treatment of transglutaminase-related diseases
06/03/2010WO2010062143A2 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
06/03/2010WO2010061971A1 Pyridine-3-carboxyamide derivative
06/03/2010WO2010061930A1 IMMUNOTHERAPEUTIC METHOD USING ALLO-CELLS WHICH CO-EXPRESS CD1d AND TARGET ANTIGEN
06/03/2010WO2010061908A1 1-(2h)-isoquinolone derivative
06/03/2010WO2010061907A1 Anti-cancer agent
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010061880A1 Vesicle preparation
06/03/2010WO2010061862A1 Antitumor agent containing thalidomide derivative as active ingredient
06/03/2010WO2010061407A1 Genetic variants useful for risk assessment of thyroid cancer
06/03/2010WO2010061360A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cylophosphamide
06/03/2010WO2010061359A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine
06/03/2010WO2010061358A1 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
06/03/2010WO2010061357A1 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
06/03/2010WO2010061329A1 3-aminocyclopentanecarboxamides as chemokine receptor modulators
06/03/2010WO2010061282A1 Derivatives of [(3-hydroxy-4 pyron-2-yl)methyl]-amine and use thereof as anti-neoplastic drugs
06/03/2010WO2010061208A2 Therapeutic treatment 555
06/03/2010WO2010061180A1 Quinoline derivatives as p13 kinase inhibitors
06/03/2010WO2010061142A2 Composition for slowing cancer cell tumor initiation in a high-risk mammal
06/03/2010WO2010061088A1 Pharmaceutical association lipoic acid and hydroxycitric acid as active ingredients
06/03/2010WO2010061074A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
06/03/2010WO2010060968A1 Regioselective reduction of fused pyrrolocarbazoles-5,7-diones
06/03/2010WO2010060940A2 Hsp90 inhibitors for therapeutic treatment
06/03/2010WO2010060937A2 Hsp90 inhibitor combinations
06/03/2010WO2010060854A1 Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents
06/03/2010WO2010060532A1 Benzonaphtyridine compounds used as inhibitors of autotaxin
06/03/2010WO2010060387A1 The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
06/03/2010WO2010060277A1 Substituted acetyl hydrazide derivatives, their preparation and uses thereof
06/03/2010WO2010060215A1 2-(n-substituted piperazinyl) steroid derivatives
06/03/2010WO2010060214A1 Hybrid -ionone and curcumin molecules as anticancer agents
06/03/2010WO2010037514A3 Novel immunotherapy against several tumors including neuronal and brain tumors
06/03/2010WO2010032248A8 Multifunctional albumin conjugates
06/03/2010WO2010030598A3 Pharmaceutical formulations comprising pemetrexed
06/03/2010WO2010027424A3 9-substituted phenanthrene based tylophorine derivatives
06/03/2010WO2010022277A3 Combination of 10-propargyl-10-deazaaminopterin and bortezomib for the treatment of cancers
06/03/2010WO2010019276A3 Method and formulation for treating adverse biological conditions
06/03/2010WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes
06/03/2010WO2009150405A8 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine
06/03/2010WO2009074020A9 Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof
06/03/2010WO2009067856A8 Histone deacetylase inhibitor, composition and use thereof
06/03/2010WO2009053715A8 Thienopyrimidiene derivatives as pi3k inhibitors
06/03/2010WO2009052090A8 Silicate containing compositions and methods of treatment
06/03/2010WO2008131348A3 Compositions and methods for treatment of uncontrolled cell growth
06/03/2010US20100138945 Humanized anti-il-6 antibodies
06/03/2010US20100138935 Detection of cellular stress
06/03/2010US20100137449 Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith
06/03/2010US20100137439 Use of aminolevulinic acid and derivatives thereof
06/03/2010US20100137435 Monoacetyldiacylglycerol Derivative for the Treatment of Sepsis
06/03/2010US20100137434 Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer
06/03/2010US20100137427 Softgel of NLKJ for treating prostate diseases
06/03/2010US20100137425 Inhibition and treatment of prostate cancer metastasis
06/03/2010US20100137421 Small molecule therapeutics, synthesis of analogues and derivatives and methods of use
06/03/2010US20100137419 Anti-cancer agent
06/03/2010US20100137415 Vector for gene therapy
06/03/2010US20100137413 Micrornaome
06/03/2010US20100137411 Ras-mediated epigenetic silencing effectors and uses thereof
06/03/2010US20100137410 Oncogenic ALL-1 Fusion Proteins for Targeting Drosha-Mediated MicroRNA Processing
06/03/2010US20100137398 Use of hdac inhibitors for the treatment of gastrointestinal cancers
06/03/2010US20100137396 Treatment of esophageal high grade dysplasia using photodynamic therapy
06/03/2010US20100137394 Pyrazole inhibitors of wnt signaling
06/03/2010US20100137386 Tnik inhibitor and the use
06/03/2010US20100137381 Acetamide derivatives as potassium channel modulators
06/03/2010US20100137363 Substituted Indoles And Methods Of Their Use
06/03/2010US20100137360 Trpv1 antagonists
06/03/2010US20100137359 Caspase inhibitors and uses thereof
06/03/2010US20100137356 Azaindole-indole coupled derivatives, preparation methods and uses thereof
06/03/2010US20100137354 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
06/03/2010US20100137350 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal compositon containing them
06/03/2010US20100137338 INHIBITORS OF Akt ACTIVITY
06/03/2010US20100137336 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
06/03/2010US20100137327 Novel semicarbazide and carbonylhydrazide derivatives useful as potassium channel modulators
06/03/2010US20100137326 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137319 Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith
06/03/2010US20100137315 Sphingosine Kinase Inhibitors and Methods of Their Use
06/03/2010US20100137312 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137305 Aminopyrimidines useful as kinase inhibitors
06/03/2010US20100137304 Novel crystalline forms of the anti-cancer compound zd1839
06/03/2010US20100137302 Fused Thiazole Derivatives as Kinase Inhibitors
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100137296 N-phenyl anthranilic acid derivatives and uses thereof
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137274 Rivaroxaban and derivatives, synthesis; atherosclerosis; arthritis; Alzheimer's disease or cancer
06/03/2010US20100137254 Phosphoramidate alkylator prodrugs
06/03/2010US20100137246 Anti-inflammatory compositions and methods
1 ... 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 ... 2211